DK442881A - Prostaglandinholdigt praeparat - Google Patents

Prostaglandinholdigt praeparat

Info

Publication number
DK442881A
DK442881A DK442881A DK442881A DK442881A DK 442881 A DK442881 A DK 442881A DK 442881 A DK442881 A DK 442881A DK 442881 A DK442881 A DK 442881A DK 442881 A DK442881 A DK 442881A
Authority
DK
Denmark
Prior art keywords
prostagland
prostaglandin
containing preparation
compositions
dissolved
Prior art date
Application number
DK442881A
Other languages
English (en)
Inventor
H E Gallo-Torres
N H Shah
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK442881A publication Critical patent/DK442881A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK442881A 1980-10-09 1981-10-06 Prostaglandinholdigt praeparat DK442881A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/195,575 US4310543A (en) 1980-10-09 1980-10-09 Prostaglandin compositions

Publications (1)

Publication Number Publication Date
DK442881A true DK442881A (da) 1982-04-10

Family

ID=22721933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK442881A DK442881A (da) 1980-10-09 1981-10-06 Prostaglandinholdigt praeparat

Country Status (13)

Country Link
US (1) US4310543A (da)
EP (1) EP0049852B1 (da)
JP (1) JPS5793911A (da)
AT (1) ATE14981T1 (da)
AU (1) AU547175B2 (da)
CA (1) CA1176567A (da)
DE (1) DE3171928D1 (da)
DK (1) DK442881A (da)
IE (1) IE51637B1 (da)
IL (1) IL63960A (da)
NZ (1) NZ198533A (da)
PH (1) PH17073A (da)
ZA (1) ZA816852B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5931711A (ja) * 1982-07-19 1984-02-20 シンテツクス（ユ−・エス・エイ）インコ−ポレ−テツド 酸単離ゼラチンにより被包したｐｇｅ型組成物
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
FR2549371B1 (fr) * 1983-07-20 1985-09-13 Sanofi Sa Nouvelle composition pharmaceutique contenant de l'acide valproique ou un de ses sels
AU3880185A (en) * 1984-02-08 1985-08-27 R.P. Scherer Corporation Acetaminophen gelatin capsule
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
DK0458588T3 (da) * 1990-05-22 1995-03-13 R Tech Ueno Ltd Behandling af okulær hypertension med en synergistisk kombination til okulær administration
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
WO2001003695A1 (en) * 1999-07-13 2001-01-18 Avmax, Inc. Improvement of bioavailability with vitamin c fatty acid esters
KR100649860B1 (ko) * 2000-09-01 2006-11-24 주식회사종근당 알프로스타딜 경점막 및 경피흡수제제
AU2001286210A1 (en) * 2000-09-13 2002-03-26 Asahi Glass Company, Limited Eye drops
EP1666043B1 (en) * 2003-07-31 2009-12-02 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
JP2007506782A (ja) * 2003-09-25 2007-03-22 アクティブバイオティクス インコーポレイティッド リファラジル製剤
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
KR101305649B1 (ko) * 2004-12-09 2013-09-09 산텐 세이야꾸 가부시키가이샤 분자 내에 불소 원자를 갖는 프로스타글란딘 함유 제품
CA2592474C (en) * 2004-12-24 2013-08-13 Santen Pharmaceutical Co., Ltd. Prostaglandin f2.alpha. derivative-containing product
BRPI0710611A2 (pt) * 2006-04-06 2011-08-16 Activbiotics Inc composições farmacêuticas e seus usos
KR101485212B1 (ko) * 2007-07-19 2015-01-22 가부시키가이샤 아루떼꾸 우에노 11-데옥시-프로스타글란딘 화합물을 포함하는 약학 조성물 및 상기 화합물을 안정화시키는 방법
WO2009052391A1 (en) * 2007-10-19 2009-04-23 Purdue Research Foundation Solid formulations of crystalline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2889252A (en) * 1956-05-14 1959-06-02 American Cyanamid Co Gelatin capsule containing hexylresorcinol and a lower polyalkylene glycol
ZA721937B (en) * 1971-10-22 1972-12-27 Upjohn Co Pharmaceutical preparations and uses thereof
CA1043259A (en) * 1972-12-08 1978-11-28 Geoffrey F. Thompson Medicament preparations and vehicles therefor
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
JPS6019734B2 (ja) * 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
JPS6046094B2 (ja) * 1977-06-01 1985-10-14 科研製薬株式会社 安定化されたプロスタグランジンｅ類粉末製剤
DK7679A (da) * 1978-01-17 1979-07-18 Sandoz Ag Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat

Also Published As

Publication number Publication date
DE3171928D1 (en) 1985-09-26
IE51637B1 (en) 1987-01-21
JPS5793911A (en) 1982-06-11
ATE14981T1 (de) 1985-09-15
EP0049852A2 (de) 1982-04-21
CA1176567A (en) 1984-10-23
IE812354L (en) 1982-04-09
ZA816852B (en) 1982-09-29
NZ198533A (en) 1984-12-14
IL63960A0 (en) 1981-12-31
EP0049852A3 (en) 1983-01-26
PH17073A (en) 1984-05-24
US4310543A (en) 1982-01-12
JPH032848B2 (da) 1991-01-17
IL63960A (en) 1985-05-31
EP0049852B1 (de) 1985-08-21
AU7606881A (en) 1982-04-22
AU547175B2 (en) 1985-10-10

Similar Documents

Publication Publication Date Title
DK442881A (da) Prostaglandinholdigt praeparat
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
ATE81588T1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
FI840832A0 (fi) Farmaceutiska sammansaettningar
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
DE69321596D1 (de) Ester und kombinationen von einem organischen nitrat und einem salicyclat
FI831998L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrazinonderivat
DK585889A (da) Farmaceutisk praeparat
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
ATE6640T1 (de) N-benzoyl-alpha-anilinoalkylcarboxylsaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
FI845019L (fi) Farmaceutiskt preparat foer behandling av reumatiska sjukdomar.
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
SE8501312D0 (sv) Etoposide oral dosage form
FR2449686B1 (fr) Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation
FI792303A (fi) Farmaceutisk komposition foer rektal administration av kefalosporin
JPS56131514A (en) Ketoprofen composition for rectum administration
BE881625A (fr) Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
JPS52130905A (en) Medicinal composition
IL56487A (en) Quaternary salts of bis isoquinolinoalkyl benzene dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them
DK295079A (da) Farmaceutisk komposition indeholdende trimethoprim og n-ethyl-gamma-pyridon-3-carboxylsyrederivater
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
DE3382348D1 (de) Tablette in form einer kapsel, verfahren und apparat fuer ihre herstellung.
JPS55361A (en) Method of using thienoyl peroxide as drug and toiletary substance and pharmaceutical and toiletary composition containing it
NO158217C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive ester-derivater av acetylsalicylsyre.
IT7927403A0 (it) Prodotto per la terapia delle coronarie sotto forma di capsule di gelatina da masticare.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment